The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, like amyloid PET scans, tau imaging, and blood-based mostly tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, https://thomass864ufo4.glifeblog.com/profile